Warfarin, not direct oral anticoagulants or antiplatelet therapy, is associated with increased bleeding risk in emergency general surgery patients: Implications in this new era of novel anticoagulants: An EAST multicenter study.
Anandalwar SP, O'Meara L, Vesselinov R, Zhang A, Baum JN, Cooper A, Decker C, Schroeppel T, Cai J, Cullinane D, Catalano RD, Bugaev N, LeClair M, Feather C, McBride K, Sams V, Leung PS, Olafson S, Callahan DS, Posluszny J, Moradian S, Estroff J, Hochman B, Coleman N, Goldenberg-Sandau A, Nahmias J, Rosenbaum K, Pasley J, Boll L, Hustad L, Reynolds J, Truitt M, Ghneim M. Warfarin, not direct oral anticoagulants or antiplatelet therapy, is associated with increased bleeding risk in emergency general surgery patients: Implications in this new era of novel anticoagulants: An EAST multicenter study. J Trauma Acute Care Surg. 2024 Aug 01; 97(2):225-232.